Literature DB >> 18212080

Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria.

Semih Esin1, Giovanna Batoni, Claudio Counoupas, Annarita Stringaro, Franca Lisa Brancatisano, Marisa Colone, Giuseppantonio Maisetta, Walter Florio, Giuseppe Arancia, Mario Campa.   

Abstract

Our previous studies demonstrated that Mycobacterium bovis bacillus Calmette-Guérin (BCG) can directly interact with human NK cells and induce the proliferation, gamma interferon production, and cytotoxic activity of such cells without the need for accessory cells. Thus, the aim of the present study was to identify the putative receptor(s) responsible for the recognition of BCG by human NK cells and potentially involved in the activation of NK cells. To this end, we first investigated the surface expression of three NK cell-activating receptors belonging to the natural cytoxicity receptor (NCR) family on highly purified human NK cells upon in vitro direct stimulation with BCG. An induction of the surface expression of NKp44, but not of NKp30 or NKp46, was observed after 3 and 4 days of in vitro stimulation with live BCG. The NKp44 induction involved mainly a particular NK cell subset expressing the CD56 marker at high density, CD56(bright). In order to establish whether NKp44 could directly bind to BCG, whole BCG cells were stained with soluble forms of the three NCRs chimeric for the human immunoglobulin G (IgG) Fc fragment (NKp30-Fc, NKp44-Fc, NKp46-Fc), followed by incubation with a phycoerythrin (PE)-conjugated goat anti-human IgG antibody. Analysis by flow cytometry of the complexes revealed a higher PE fluorescence intensity for BCG incubated with NKp44-Fc than for BCG incubated with NKp30-Fc, NKp46-Fc, or negative controls. The binding of NKp44-Fc to the BCG surface was confirmed with immunogold labeling using transmission electron microscopy, suggesting the presence of a putative ligand(s) for human NKp44 on the BCG cell wall. Similar binding assays performed on a number of gram-positive and gram-negative bacteria revealed a pattern of NKp44-Fc binding restricted to members of the genus Mycobacterium, to the mycobacterium-related species Nocardia farcinica, and to Pseudomonas aeruginosa. Altogether, the results obtained indicate, for the first time, that at least one member of the NCR family (NKp44) may be involved in the direct recognition of bacterial pathogens by human NK cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18212080      PMCID: PMC2292874          DOI: 10.1128/IAI.00870-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Unravelling natural killer cell function: triggering and inhibitory human NK receptors.

Authors:  Lorenzo Moretta; Alessandro Moretta
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

Review 2.  Mycolic acids: structure, biosynthesis and physiological functions.

Authors:  C E Barry; R E Lee; K Mdluli; A E Sampson; B G Schroeder; R A Slayden; Y Yuan
Journal:  Prog Lipid Res       Date:  1998 Jul-Aug       Impact factor: 16.195

3.  Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Myco. avium.

Authors:  S Esin; G Batoni; G Källenius; H Gaines; M Campa; S B Svenson; R Andersson; H Wigzell
Journal:  Clin Exp Immunol       Date:  1996-06       Impact factor: 4.330

4.  Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma.

Authors:  S Nylén; K Maasho; K Söderstrom; T Ilg; H Akuffo
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

5.  Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure.

Authors:  Giovanni Delogu; Cinzia Pusceddu; Alessandra Bua; Giovanni Fadda; Michael J Brennan; Stefania Zanetti
Journal:  Mol Microbiol       Date:  2004-05       Impact factor: 3.501

6.  KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.

Authors:  Akiko Kikuchi-Maki; Sei-ichi Yusa; Tracey L Catina; Kerry S Campbell
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

7.  Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin.

Authors:  Semih Esin; Giovanna Batoni; Manuela Pardini; Flavia Favilli; Daria Bottai; Giuseppantonio Maisetta; Walter Florio; Renato Vanacore; Hans Wigzell; Mario Campa
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

8.  Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44.

Authors:  Oren Hershkovitz; Sergey Jivov; Noga Bloushtain; Alon Zilka; Guy Landau; Ahuva Bar-Ilan; Rachel G Lichtenstein; Kerry S Campbell; Toin H van Kuppevelt; Angel Porgador
Journal:  Biochemistry       Date:  2007-05-31       Impact factor: 3.162

9.  Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production.

Authors:  Anick Chalifour; Pascale Jeannin; Jean-François Gauchat; Aline Blaecke; Martine Malissard; Thien N'Guyen; Nathalie Thieblemont; Yves Delneste
Journal:  Blood       Date:  2004-05-27       Impact factor: 22.113

10.  NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.

Authors:  M Vitale; C Bottino; S Sivori; L Sanseverino; R Castriconi; E Marcenaro; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  64 in total

1.  High rate of Quantiferon positive and tuberculin negative tests in infants born at a large Italian university hospital in 2011: a cautionary hypothesis.

Authors:  Antonio Cassone; Roberto Cauda; Andrea De Maria
Journal:  Pathog Glob Health       Date:  2012-03       Impact factor: 2.894

2.  Antibacterial role for natural killer cells in host defense to Bacillus anthracis.

Authors:  Christine M Gonzales; Courtney B Williams; Veronica E Calderon; Matthew B Huante; Scott T Moen; Vsevolod L Popov; Wallace B Baze; Johnny W Peterson; Janice J Endsley
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

Review 3.  Natural killer cells in immunodefense against infective agents.

Authors:  Nicolas Zucchini; Karine Crozat; Thomas Baranek; Scott H Robbins; Marcus Altfeld; Marc Dalod
Journal:  Expert Rev Anti Infect Ther       Date:  2008-12       Impact factor: 5.091

4.  Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity.

Authors:  Charles T Spencer; Getahun Abate; Azra Blazevic; Daniel F Hoft
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 5.  Evasion from NK cell-mediated immune responses by HIV-1.

Authors:  Stephanie Jost; Marcus Altfeld
Journal:  Microbes Infect       Date:  2012-05-21       Impact factor: 2.700

Review 6.  Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity.

Authors:  A Fuchs; M Colonna
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

Review 7.  The role of the gut and microbes in the pathogenesis of spondyloarthritis.

Authors:  Mark Asquith; Dirk Elewaut; Phoebe Lin; James T Rosenbaum
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-15       Impact factor: 4.098

8.  Exposure of cord blood to Mycobacterium bovis BCG induces an innate response but not a T-cell cytokine response.

Authors:  M L V Watkins; P L Semple; B Abel; W A Hanekom; G Kaplan; S R Ress
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

Review 9.  The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.

Authors:  Jessica A Hamerman; Minjian Ni; Justin R Killebrew; Ching-Liang Chu; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

10.  Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.

Authors:  Mostafa Jarahian; Carsten Watzl; Philippe Fournier; Annette Arnold; Dominik Djandji; Sarah Zahedi; Adelheid Cerwenka; Annette Paschen; Volker Schirrmacher; Frank Momburg
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.